Altria Group, Inc.

NYSE•MO

執行長: Mr. William F. Gifford Jr.

板塊: Consumer Defensive

行業: Tobacco

上市日期: 1985-07-01

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.

聯絡資訊

6601 West Broad Street, Richmond, VA, 23230, United States

804-274-2200

www.altria.com

市值

$113.97B

本益比 (TTM)

16.3

19.4

股息率

6.1%

52周最高

$70.51

52周最低

$52.82

52周範圍

85%

排名13Top 2.2%

6.8

F-Score

改良版 Piotroski 分析

基於 10 年期基本面

強勁 • 6.8 / 9 分

評分區間 (0-9)

8-9: 價值優異

6-7: 基本面強勁

4-5: 整體穩健

0-3: 表現疲弱

資料區間: 2016-2025

財務儀表板

Q4 2025 數據

營業收入

$5.85B+14.49%

近4季度走勢

每股收益

$0.66-63.33%

近4季度走勢

自由現金流

$3.18B-3.46%

近4季度走勢

2025 Annual 財報亮點

核心亮點

Adjusted Earnings Growth Adjusted Net Earnings grew 2.4% to $9.15B USD; Adjusted Diluted EPS increased 4.4% to $5.42 USD.

Cigarette Volume Decline Total cigarette shipments fell 10.0% to 61.8B units in 2025, driven by down-trading pressures.

Major E-Vapor Impairments Recorded $2.13B in asset impairment charges, including $1.16B goodwill impairment for e-vapor unit.

Share Repurchase Activity Repurchased $1.0B common stock during Q4 2025 under the January 2025 program authorization.

關注風險

Illicit E-Vapor Competition Illicit flavored disposable e-vapor products continue to drive cigarette volume decline and challenge growth.

E-Vapor Asset Devaluation E-vapor reporting unit goodwill impaired by $1.16B due to protracted enforcement against illicit flavored products.

Tobacco Litigation Uncertainty Ongoing tobacco and health litigation remains subject to uncertainty, potentially resulting in material adverse effects.

Premium Brand Down-trading Macroeconomic pressures caused consumers to reduce consumption and purchase lower-priced discount brands.

未來展望

2028 EPS Growth Target Targeting mid-single digit adjusted diluted EPS CAGR by 2028 from a $4.87 base in 2022.

Optimize & Accelerate Savings Initiative expects to deliver cumulative savings of at least $600M by the end of fiscal year 2029.

Progressive Dividend Goal Maintain progressive dividend goal targeting mid-single digits dividend per share growth annually through 2028.

Smoke-Free Portfolio Focus Remain committed to building FDA-authorized smoke-free product portfolio beyond current nicotine categories.

同行對比

營業收入 (TTM)

$123.01B

-7.0%

TGT

$105.64B

-1.4%

BUD

$89.38B

+0.0%

毛利率 (最新季度)

100.0%

+0.0pp

BTI

83.4%

+1.1pp

62.1%

-8.5pp

關鍵指標

股票代碼	市值	本益比 (TTM)	股東權益報酬率 (TTM)	負債率
BUD	$141.38B	13.8	12.3%	33.4%
UL	$139.96B	28.2	26.0%	42.0%
BTI	$130.30B	12.5	16.3%	32.1%

長期趨勢

近4季度

營業收入

淨利

營運現金流

4季度營業收入複合增長率

9.0%

穩定增長

4季度淨利複合增長率

1.2%

盈利能力緩慢提升

現金流穩定性

100%

現金流表現優異

深度研究

下次財報:2026年4月27日

每股收益:-

營業收入:-

財務數據

電話會議

財務報告

新聞

損益表

資產負債表

現金流量表

財務比率

變化率

損益表	過去12個月

無資料